Stockreport

Intra-Cellular bolsters Caplyta data with another Phase III win [Yahoo! Finance]

Intra-Cellular Therapies Inc.  (ITCI) 
Last intra-cellular therapies inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intracellulartherapies.com/investor-relations
PDF from a Phase III trial of the therapy for prevention in relapse in schizophrenia patients. The Study 304 (NCT04959032) trial met its primary endpoint of time to relaps [Read more]